S&P Biotech SPDR (XBI)

$90.87 0.49 (0.54%)

17:00 EDT XBI Stock Quote Delayed 30 Minutes

The 3 Most Undervalued Biotech Stocks to Buy in June 2024

By Ian Cooper, InvestorPlace Contributor Jun 4, 2024

Undervalued biotech stocks can offer some of the most explosive opportunities. That is, if you can spot the right one at the right time. Many…

5 Healthcare Stocks to Buy for 2024

3 Biotech Stocks to Buy on the Dip: March 2024

3 Biotech ETFs Overdue for a Bounce

Volume:

Previous Close -

Market Cap 68.47M

PE Ratio -

EPS -

Volume (Avg. Vol.) 4.68M

Day's Range $90.54 - $92.18

52-Week Range $63.80 - $103.52

Dividend & Yield $0.003 (0.00%)

XBI Stock Predictions, Articles, and S&P Biotech SPDR News

Don’t Miss the Boom: 3 ETFs Set to Explode Higher

By Ian Bezek, InvestorPlace Contributor Sep 27, 2023

The market may be uncertain. But these three ETFs to buy are set to deliver fantastic returns regardless of the broader economic climate.

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

By Josh Enomoto, InvestorPlace Contributor Mar 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond

By Ian Cooper, InvestorPlace Contributor Dec 18, 2022

Some of the hottest biotech stocks are safe and recession-proof. After all, we can’t stop people from aging – at least, not yet. We can’t…

The 7 Best Market Sectors for Q4

By Chris Markoch, InvestorPlace Contributor Sep 18, 2022

The seven best market sectors for the fourth quarter are home to top-performing stocks and ideas that will benefit even in a slowing economy.

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry

By Samuel O'Brient, InvestorPlace Reporter Sep 12, 2022

President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.

3 Stocks to Sell Now

By Tyler Craig, Tales of a Technician Jun 30, 2022

Equities continue to suffer from the highest inflation readings of a generation. Here are three S&P 500 stocks to sell before things get worse.

3 Beaten-Down ETFs to Buy Before They Rebound

By Tyler Craig, Tales of a Technician Jun 23, 2022

The charts are improving for these fallen angels, and that makes them all top ETFs to buy for the back half of the year.

3 Market ETF Stocks to Buy This Week on Fed Jitters

By Nicolas Chahine, InvestorPlace Contributor Mar 14, 2022

The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over.

3 Biotech Stocks to Buy That Are Under Severe Pressure

By Nicolas Chahine, InvestorPlace Contributor Jan 13, 2022

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

3 Stocks to Buy for the Second Half of 2021

By Nicolas Chahine, InvestorPlace Contributor Aug 9, 2021

Even at all time high indices there are stocks to buy. Today we find three swing trade opportunities while the bulls are in charge.

3 Top Stock Trades for the Week

By Tyler Craig, Tales of a Technician Jun 8, 2021

These three ETFs were red-hot on Monday, making them obvious choices for this week's top stock trades. Here's how to play them with options.

7 Best Equal-Weight ETFs To Buy In June

By Tezcan Gecgil, InvestorPlace Contributor Jun 4, 2021

Financial planners highlight the benefits of ETFs track an equal-weighted index. Here are seven of the leading ETFs to consider in June.

7 Best Tech Index Funds for the Long-Haul Despite the Current Selloff

By Tezcan Gecgil, InvestorPlace Contributor May 24, 2021

The tech sector has been under pressure, but these seven index funds offer exposure to a range of tech shares and could become the building blocks of a successful growth portfolio.

3 Biotech Stocks to Buy As Things Heat Up for the Sector

By Tyler Craig, Tales of a Technician Feb 18, 2021

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high. Here's how to play it.

The Cusp of an Amazing Technological Revolution

By Louis Navellier, Editor, Growth Investor Dec 15, 2020

We’re again at the cusp of an amazing technological revolution that will carry the stock market to incredible new highs. Make sure to position yourself to take advantage of this huge profit potential.

7 Index Funds To Buy For Diversified Growth in 2021

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Dec 7, 2020

Index funds offer investors the opportunity for diversified growth. With the S&P 500 and Dow Jones up so much in 2020, here are 7 others.

4 Biotech Stocks to Buy for Big Gains in 2020

By Tezcan Gecgil, InvestorPlace Contributor Sep 18, 2020

The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.

3 Biotech Stock ETFs to Buy For Further Upside In 2021

By Nicolas Chahine, InvestorPlace Contributor Aug 17, 2020

Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

By Todd Shriber, InvestorPlace Contributor Aug 4, 2020

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

3 Healthcare Stocks to Buy This Year

By Nicolas Chahine, InvestorPlace Contributor Feb 24, 2020

The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.

S&P Biotech SPDR (XBI)

The 3 Most Undervalued Biotech Stocks to Buy in June 2024

5 Healthcare Stocks to Buy for 2024

3 Biotech Stocks to Buy on the Dip: March 2024

3 Biotech ETFs Overdue for a Bounce

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

S&P Biotech SPDR (XBI)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

XBI Stock Predictions, Articles, and S&P Biotech SPDR News

Subscriber Sign in